Canopy Growth Corp Long-Term Debt, Maturity, after Year Five
Canopy Growth Corp (CGC) had Long-Term Debt, Maturity, after Year Five of CAD 55.00 million as of 2026-03-31, per its 10-K filed 2026-06-15.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2026-06-15
- 2026-03-31: Long-Term Debt, Maturity, after Year Five 55.00M CAD.
- 2020-03-31: Long-Term Debt, Maturity, after Year Five 246.00K CAD.
| Period end | Long-Term Debt, Maturity, after Year Five |
|---|---|
| 2026-03-31 | 55.00M CAD 10-K · filed 2026-06-15 |
| 2020-03-31 | 246.00K CAD 10-K · filed 2020-06-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |